Osmotica Pharmaceuticals PLC reports results for the quarter ended in June - Earnings Summary

RVL Pharmaceuticals

17/08/2021 07:26

* Osmotica Pharmaceuticals PLC  OSMT.OQ  reported a quarterly
adjusted loss of 28 cents​​ per share for the quarter ended in
June. The mean expectation of two analysts for the quarter was
for a loss of 14 cents per share.
* Revenue fell 69.3% to $11.51 million from a year ago; 
analysts expected $34.55 million. 
* Osmotica Pharmaceuticals PLC's reported EPS for the quarter
was a loss of 28 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Osmotica Pharmaceuticals PLC shares had risen by 35.5% this
quarter and lost 1.0% so far this year.
* The company reported a quarterly loss of $17.73 million.
* Wall Street's median 12-month price target for Osmotica
Pharmaceuticals PLC is $7.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 17 at 06:25 a.m.  ​All
figures in US dollars unless otherwise stated